Search for: "Mylan, Inc."
Results 541 - 560
of 587
Sorted by Relevance
|
Sort by Date
26 Jan 2015, 4:03 am
.* JUST OUT - Molecular weights at the Supreme Court - Teva v SandozThe IPKat has already covered the UK litigation of Generics (t/a Mylan) v Yeda/Teva, in which a patent that covered glatiramer acetate was held valid even though the claims specified a particular molecular weight range without specifying what method was used to measure that weight (here, here, and here). [read post]
31 Jan 2014, 7:26 am
Mylan, Inc., No. 12-2502, 2013 U.S. [read post]
1 Oct 2009, 2:14 am
Mylan Pharmaceuticals, 2008 WL 3540462 (N.D.W. [read post]
30 Apr 2007, 10:51 am
Mylan Labs, Inc., 464 F.3d 1286, 1291 (2006)), even if the advantage was not one that the inventor contemplated or that the patent itself disclosed. [read post]
14 Mar 2011, 8:12 pm
(forthcoming)Motion for leave to file out of time amicus brief of American Bankers AssociationPetitioner's reply Title: Mylan Inc. v. [read post]
30 Apr 2007, 4:50 pm
Mylan Labs, Inc., 464 F.3d 1286, 1291 (2006)), even if the advantage was not one that the inventor contemplated or that the patent itself disclosed. [read post]
3 Feb 2011, 2:11 pm
Mylan Pharmaceuticals., Inc., 696 F. [read post]
23 Dec 2007, 8:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]GlobalEvents in Bali heap further pressure on all IP owners: (IAM),Velcro defies generic claim in domain name battle: (OUT-LAW),ICANN forms group to hasten non-English domain names: (IP Justice)WTO members continue debate on geographical indications register: (Intellectual Property Watch),Creative Commons launches CCo and CC programs: (World IP Day),Green IP Strategy - risks… [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]
28 Jun 2007, 10:16 am
Pfizer, Inc., ___ F. [read post]
18 Aug 2022, 4:43 am
Suzanne prosecuted many notable FCA cases in the government, including several qui tam cases against National Medicare Care, Inc. [read post]
9 Apr 2009, 7:52 am
(IP Think Tank) Brazilian public-private partnerships in the pharma industry (IP tango) EU: ECJ to rule on reference on SPC Regulation interpretation from Lithuania in Kirin Amgen, Inc. v Lietuvos Respublikos valstybinis patentų biuras (The SPC Blog) India: Delhi High Court Dasatinib order: Is patent-drug regulatory linkage a necessity? [read post]
8 Sep 2011, 12:59 pm
., a maker and distributor of generic drugs, engaged in an illegal drug- switching scheme to increase sales, the U.S. said in a lawsuit in which two Mylan Inc. units are also accused by a whistleblower of wrongdoing. [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram) – US:… [read post]
25 Jan 2022, 8:13 am
EHR Company Athenahealth Settles Case for $18.25 Million in January 2021 Our first False Claims Act settlement of 2021 resolved allegations that athenahealth Inc. [read post]
17 Dec 2009, 11:22 am
Mylan, Inc., 2009 WL 4730820 (S.D.W. [read post]
7 Feb 2008, 10:46 am
Medtronic, Inc., 231 F.3d 216, 230 (6th Cir. 2001).Kemp concluded that the purported "violations" before it were not violations at all - but merely reflected Plaintiffs' incorrect reading of FDA requirements. [read post]
26 May 2011, 10:54 am
Mylan, Inc., 718 F. [read post]
23 Oct 2008, 9:03 am
See Albertsons, Inc., v. [read post]
28 Oct 2011, 7:00 am
Mylan Pharmaceuticals, Inc., 751 F. [read post]
